Drugmaker Pozen is reporting that a recent trial has shown that its new migraine medication Treximet does not cause genetic damage in patients who take the drug. In the study, Treximet--formerly known as Trexima--did not cause chromosomal changes in migraine patients who took the drug for seven days. Treximet is a combination of the active ingredient in Imitrex and naproxen sodium. It is currently under consideration for approval by the U.S. Food and Drug Administration.
Read moreIn our Question and Answer section and in my email, I'm seeing some questions about "passing" drug screenings when taking medications for... Read more »
Full Question:I am 28 years old and have suffered from migraines since about the age of 20. The symptoms have always been pretty similar... Read more »
It is with profound sadness that the Migraine Research Foundation mourns the death of Dr. Fred Sheftell. A member of our Medical... Read more »
Wow! How quickly this summer is passing. It seems that I wrote about the July Headache and Migraine Blog Carnival, and here it is time to... Read more »
We have had a number of members of this site who have successfully applied for and been granted Intermittent Family Medical Leave Act... Read more »
Wondering what's new? It can be tough to keep up with new information on MyMigraineConnection -- ... new articles about Migraines, medications, ... Read more »
Marcia Cross, a wife and mother of twin daughters, has a thriving acting career despite Migraine disease. She was born in Marlborough,... Read more »
Dietary supplements are an important part of many treatment regimens for headache and Migraine prevention. When we buy supplements, most of us assume... Read more »
Source: Harvard Decision Guide
What Is It? A migraine is a very common, but very particular, type of headache. Most people who get migraines have repeated attacks of headaches that... Read more »
Scientists are testing a theory that fixing a common heart defect will stop migraines. About 20 percent of all adults have a small hole that allows... Read more »